# Avantor, Inc.: financial statements, quarterly

AVTR · NYSE · CIK 1722482 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/avtr.md) · [Financials](/companies/avtr/financials.md) · [Filings](/companies/avtr/filings.md) · [Insiders](/companies/avtr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/avtr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,723 d](/filings/0001628280-26-007118.md) | [1,680](/filings/0001722482-25-000080.md) | [1,703](/filings/0001722482-25-000190.md) | [1,714](/filings/0001628280-25-046936.md) | [1,687 d](/filings/0001628280-26-007118.md) | [1,581](/filings/0001628280-26-028141.md) | [1,683](/filings/0001628280-26-050415.md) | [1,624](/filings/0001628280-26-067751.md) | [1,664 d](/filings/0001628280-26-007118.md) | [1,581](/filings/0001628280-26-028141.md) | [1,692](/filings/0001628280-26-050415.md) | [1,698](/filings/0001628280-26-067751.md) |
| Cost of revenue | $m | [1,152 d](/filings/0001628280-26-007118.md) | [1,109](/filings/0001722482-25-000080.md) | [1,121](/filings/0001722482-25-000190.md) | [1,150](/filings/0001628280-25-046936.md) | [1,124 d](/filings/0001628280-26-007118.md) | [1,047](/filings/0001628280-26-028141.md) | [1,129](/filings/0001628280-26-050415.md) | [1,097](/filings/0001628280-26-067751.md) | [1,140 d](/filings/0001628280-26-007118.md) | [1,081](/filings/0001628280-26-028141.md) | [1,155](/filings/0001628280-26-050415.md) | [1,164](/filings/0001628280-26-067751.md) |
| Gross profit | $m | [570 d](/filings/0001628280-26-007118.md) | [571](/filings/0001722482-25-000080.md) | [582](/filings/0001722482-25-000190.md) | [564](/filings/0001628280-25-046936.md) | [563 d](/filings/0001628280-26-007118.md) | [535](/filings/0001628280-26-028141.md) | [554](/filings/0001628280-26-050415.md) | [527](/filings/0001628280-26-067751.md) | [524 d](/filings/0001628280-26-007118.md) | [501](/filings/0001628280-26-028141.md) | [537](/filings/0001628280-26-050415.md) | [535](/filings/0001628280-26-067751.md) |
| Selling, general and administrative | $m | [387 d](/filings/0001628280-26-007118.md) | [424](/filings/0001722482-25-000080.md) | [406](/filings/0001722482-25-000190.md) | [440](/filings/0001628280-25-046936.md) | [371 d](/filings/0001628280-26-007118.md) | [388](/filings/0001628280-26-028141.md) | [425](/filings/0001628280-26-050415.md) | [390](/filings/0001628280-26-067751.md) | [392 d](/filings/0001628280-26-007118.md) | [401](/filings/0001628280-26-028141.md) | [415](/filings/0001628280-26-050415.md) | [395](/filings/0001628280-26-067751.md) |
| Operating income | $m | [183 d](/filings/0001628280-26-007118.md) | [146](/filings/0001722482-25-000080.md) | [176](/filings/0001722482-25-000190.md) | [125](/filings/0001628280-25-046936.md) | [638 d](/filings/0001628280-26-007118.md) | [147](/filings/0001628280-26-028141.md) | [129](/filings/0001628280-26-050415.md) | [(649)](/filings/0001628280-26-067751.md) | [126 d](/filings/0001628280-26-007118.md) | [99.5](/filings/0001628280-26-028141.md) | [122](/filings/0001628280-26-050415.md) | [140](/filings/0001628280-26-067751.md) |
| Interest expense | $m | [65.3 d](/filings/0001722482-24-000012.md) | [64.3](/filings/0001722482-25-000080.md) | [60.9](/filings/0001722482-25-000190.md) | [48.7](/filings/0001628280-25-046936.md) | [44.9 d](/filings/0001628280-26-007118.md) | [42.2](/filings/0001628280-26-028141.md) | [43.4](/filings/0001628280-26-050415.md) | [44.2](/filings/0001628280-26-067751.md) | [40.0 d](/filings/0001628280-26-007118.md) | [42.9](/filings/0001628280-26-028141.md) | [39.4](/filings/0001628280-26-050415.md) | [39.9](/filings/0001628280-26-067751.md) |
| Income tax | $m | [21.0 d](/filings/0001628280-26-007118.md) | [20.2](/filings/0001722482-25-000080.md) | [21.7](/filings/0001722482-25-000190.md) | [16.7](/filings/0001628280-25-046936.md) | [83.8 d](/filings/0001628280-26-007118.md) | [21.2](/filings/0001628280-26-028141.md) | [17.0](/filings/0001628280-26-050415.md) | [22.3](/filings/0001628280-26-067751.md) | [28.4 d](/filings/0001628280-26-007118.md) | [12.2](/filings/0001628280-26-028141.md) | [43.1](/filings/0001628280-26-050415.md) | [(105)](/filings/0001628280-26-067751.md) |
| Net income | $m | [98.5 d](/filings/0001628280-26-007118.md) | [60.4](/filings/0001722482-25-000080.md) | [92.9](/filings/0001722482-25-000190.md) | [57.8](/filings/0001628280-25-046936.md) | [500 d](/filings/0001628280-26-007118.md) | [64.5](/filings/0001628280-26-028141.md) | [64.7](/filings/0001628280-26-050415.md) | [(712)](/filings/0001628280-26-067751.md) | [52.4 d](/filings/0001628280-26-007118.md) | [43.3](/filings/0001628280-26-028141.md) | [38.1](/filings/0001628280-26-050415.md) | [203](/filings/0001628280-26-067751.md) |
| Diluted EPS | $ per share | not reported | [0.09](/filings/0001722482-25-000080.md) | [0.14](/filings/0001722482-25-000190.md) | [0.08](/filings/0001628280-25-046936.md) | not reported | [0.09](/filings/0001628280-26-028141.md) | [0.09](/filings/0001628280-26-050415.md) | [(1.04)](/filings/0001628280-26-067751.md) | not reported | [0.06](/filings/0001628280-26-028141.md) | [0.06](/filings/0001628280-26-050415.md) | [0.30](/filings/0001628280-26-067751.md) |
| Basic EPS | $ per share | not reported | [0.09](/filings/0001722482-25-000080.md) | [0.14](/filings/0001722482-25-000190.md) | [0.08](/filings/0001628280-25-046936.md) | not reported | [0.09](/filings/0001628280-26-028141.md) | [0.09](/filings/0001628280-26-050415.md) | [(1.04)](/filings/0001628280-26-067751.md) | not reported | [0.06](/filings/0001628280-26-028141.md) | [0.06](/filings/0001628280-26-050415.md) | [0.30](/filings/0001628280-26-067751.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.3](/filings/0001722482-25-000015.md) | [0.2](/filings/0001722482-24-000102.md) | [0.3](/filings/0001722482-24-000145.md) | [0.3](/filings/0001722482-24-000163.md) | [0.3](/filings/0001628280-26-007118.md) | [0.3](/filings/0001722482-25-000080.md) | [0.4](/filings/0001722482-25-000190.md) | [0.3](/filings/0001628280-25-046936.md) | [0.4](/filings/0001628280-26-067751.md) | [0.3](/filings/0001628280-26-028141.md) | [0.3](/filings/0001628280-26-050415.md) | [0.5](/filings/0001628280-26-067751.md) |
| Current assets | $bn | [2.4](/filings/0001722482-25-000015.md) | [2.3](/filings/0001722482-24-000102.md) | [2.3](/filings/0001722482-24-000145.md) | [2.5](/filings/0001722482-24-000163.md) | [2.1](/filings/0001628280-26-007118.md) | [2.3](/filings/0001722482-25-000080.md) | [2.5](/filings/0001722482-25-000190.md) | [2.3](/filings/0001628280-25-046936.md) | [2.5](/filings/0001628280-26-067751.md) | [2.4](/filings/0001628280-26-028141.md) | [2.5](/filings/0001628280-26-050415.md) | [2.6](/filings/0001628280-26-067751.md) |
| Total assets | $bn | [13.0](/filings/0001722482-25-000015.md) | [12.8](/filings/0001722482-24-000102.md) | [12.7](/filings/0001722482-24-000145.md) | [12.8](/filings/0001722482-24-000163.md) | [12.1](/filings/0001628280-26-007118.md) | [12.3](/filings/0001722482-25-000080.md) | [12.8](/filings/0001722482-25-000190.md) | [11.7](/filings/0001628280-25-046936.md) | [11.8](/filings/0001628280-26-067751.md) | [11.7](/filings/0001628280-26-028141.md) | [11.6](/filings/0001628280-26-050415.md) | [11.6](/filings/0001628280-26-067751.md) |
| Current liabilities | $bn | [1.5](/filings/0001722482-25-000015.md) | [1.4](/filings/0001722482-24-000102.md) | [1.5](/filings/0001722482-24-000145.md) | [1.6](/filings/0001722482-24-000163.md) | [2.0](/filings/0001628280-26-007118.md) | [2.0](/filings/0001722482-25-000080.md) | [2.6](/filings/0001722482-25-000190.md) | [1.5](/filings/0001628280-25-046936.md) | [1.4](/filings/0001628280-26-067751.md) | [1.4](/filings/0001628280-26-028141.md) | [1.4](/filings/0001628280-26-050415.md) | [1.4](/filings/0001628280-26-067751.md) |
| Total liabilities | $bn | [7.7](/filings/0001722482-25-000015.md) | [7.4](/filings/0001722482-24-000102.md) | [7.3](/filings/0001722482-24-000145.md) | [7.3](/filings/0001722482-24-000163.md) | [6.2](/filings/0001628280-26-007118.md) | [6.2](/filings/0001722482-25-000080.md) | [6.5](/filings/0001722482-25-000190.md) | [6.1](/filings/0001628280-25-046936.md) | [6.2](/filings/0001628280-26-067751.md) | [6.1](/filings/0001628280-26-028141.md) | [6.0](/filings/0001628280-26-050415.md) | [5.8](/filings/0001628280-26-067751.md) |
| Long-term debt | $bn | [5.3](/filings/0001722482-25-000015.md) | [5.0](/filings/0001722482-24-000102.md) | [4.9](/filings/0001722482-24-000145.md) | [4.7](/filings/0001722482-24-000163.md) | [3.2](/filings/0001628280-26-007118.md) | [3.3](/filings/0001722482-25-000080.md) | [3.0](/filings/0001722482-25-000190.md) | [3.6](/filings/0001628280-25-046936.md) | [3.9](/filings/0001628280-26-067751.md) | [3.8](/filings/0001628280-26-028141.md) | [3.7](/filings/0001628280-26-050415.md) | [3.6](/filings/0001628280-26-067751.md) |
| Current portion of debt | $bn | [0.3](/filings/0001722482-25-000015.md) | [0.3](/filings/0001722482-24-000102.md) | [0.3](/filings/0001722482-24-000145.md) | [0.2](/filings/0001722482-24-000163.md) | [0.8](/filings/0001628280-26-007118.md) | [0.8](/filings/0001722482-25-000080.md) | [1.3](/filings/0001722482-25-000190.md) | [0.2](/filings/0001628280-25-046936.md) | [0.0](/filings/0001628280-26-067751.md) | [0.0](/filings/0001628280-26-028141.md) | [0.0](/filings/0001628280-26-050415.md) | [0.0](/filings/0001628280-26-067751.md) |
| Shareholders' equity | $bn | [5.3](/filings/0001628280-26-007118.md) | [5.3](/filings/0001722482-25-000190.md) | [5.4](/filings/0001628280-25-046936.md) | [5.6](/filings/0001628280-25-046936.md) | [6.0](/filings/0001628280-26-067751.md) | [6.1](/filings/0001628280-26-050415.md) | [6.3](/filings/0001628280-26-067751.md) | [5.6](/filings/0001628280-26-067751.md) | [5.6](/filings/0001628280-26-067751.md) | [5.6](/filings/0001628280-26-050415.md) | [5.6](/filings/0001628280-26-067751.md) | [5.8](/filings/0001628280-26-067751.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [252 d](/filings/0001628280-26-007118.md) | [142](/filings/0001722482-25-000080.md) | [281 d](/filings/0001722482-25-000190.md) | [245 d](/filings/0001628280-25-046936.md) | [173 d](/filings/0001628280-26-007118.md) | [109](/filings/0001628280-26-028141.md) | [154 d](/filings/0001628280-26-050415.md) | [207 d](/filings/0001628280-26-067751.md) | [153 d](/filings/0001628280-26-007118.md) | [58.7](/filings/0001628280-26-028141.md) | [178 d](/filings/0001628280-26-050415.md) | [195 d](/filings/0001628280-26-067751.md) |
| Capital expenditure | $m | [50.6 d](/filings/0001628280-26-007118.md) | [34.7](/filings/0001722482-25-000080.md) | [45.8 d](/filings/0001722482-25-000190.md) | [40.8 d](/filings/0001628280-25-046936.md) | [27.5 d](/filings/0001628280-26-007118.md) | [28.0](/filings/0001628280-26-028141.md) | [29.6 d](/filings/0001628280-26-050415.md) | [35.7 d](/filings/0001628280-26-067751.md) | [35.5 d](/filings/0001628280-26-007118.md) | [33.5](/filings/0001628280-26-028141.md) | [37.6 d](/filings/0001628280-26-050415.md) | [38.9 d](/filings/0001628280-26-067751.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [678](/filings/0001722482-24-000102.md) | [675](/filings/0001722482-24-000145.md) | [679](/filings/0001722482-24-000163.md) | [681](/filings/0001722482-25-000080.md) | [683](/filings/0001722482-25-000190.md) | [683](/filings/0001628280-25-046936.md) | [682](/filings/0001628280-26-028141.md) | [682](/filings/0001628280-26-050415.md) | [682](/filings/0001628280-26-067751.md) | [677](/filings/0001628280-26-028141.md) | [677](/filings/0001628280-26-050415.md) | [681](/filings/0001628280-26-067751.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 677,615,769 at 2026-10-23, from the cover of the [10-Q filed 2026-10-28](/filings/0001628280-26-067751.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 28, 2026, 09:10 ET. No prices; not investment advice.